Name | [5-(3-Amino-5-{[4-(trifluoromethoxy)phenyl]sulfonyl}-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methanol |
---|---|
Synonyms |
[5-(3-Amino-5-{[4-(trifluoromethoxy)phenyl]sulfonyl}-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methanol
1,3,4-Oxadiazole-2-methanol, 5-[3-amino-5-[[4-(trifluoromethoxy)phenyl]sulfonyl]-2-pyridinyl]- |
Description | Navocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1)[1]. |
---|---|
Related Catalog | |
Target |
CFTR[1] |
In Vitro | Navocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator[1]. |
References |
[1]. US 20200377491 Al |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 634.0±65.0 °C at 760 mmHg |
Molecular Formula | C15H11F3N4O5S |
Molecular Weight | 416.33 |
Flash Point | 337.2±34.3 °C |
Exact Mass | 416.040222 |
LogP | 2.50 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.581 |